{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:48:49Z","timestamp":1783648129043,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.radcr.2024.03.051","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T03:06:17Z","timestamp":1718679977000},"page":"3757-3762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of 18F-FDG PET\/CT and 18F-DOTATATE PET\/CT in the diagnosis of multiple metastases in rectal neuroendocrine neoplasms"],"prefix":"10.1016","volume":"19","author":[{"given":"Zhihui","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radcr.2024.03.051_bib0001","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1530\/ERC-20-0036","article-title":"Neuroendocrine neoplasm update: toward universal nomenclature","volume":"27","author":"Rindi","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.radcr.2024.03.051_bib0002","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000481390","article-title":"Neuroendocrine neoplasms: dichotomy, origin, and classifications","volume":"33","author":"Kl\u00f6ppel","year":"2017","journal-title":"Visc Med"},{"key":"10.1016\/j.radcr.2024.03.051_bib0003","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00535-014-0934-2","article-title":"Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis","volume":"50","author":"Ito","year":"2015","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.radcr.2024.03.051_bib0004","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11154-020-09607-z","article-title":"Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer","volume":"22","author":"Klomp","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.radcr.2024.03.051_bib0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.radcr.2024.03.051_bib0006","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12022-016-9436-5","article-title":"Expression of somatostatin receptor type 2A and PTEN in neuroendocrine neoplasms is associated with tumor grade but not with site of origin","volume":"27","author":"Wada","year":"2016","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.radcr.2024.03.051_bib0007","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.2967\/jnumed.116.186502","article-title":"Clinical history of the theranostic radionuclide approach to neuroendocrine tumors and other types of cancer: historical review based on an interview of Eric P. Krenning by Rachel Levine","volume":"58","author":"Levine","year":"2017","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.radcr.2024.03.051_bib0008","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2967\/jnumed.120.251512","article-title":"Somatostatin receptor imaging and theranostics: current practice and future prospects[J]","volume":"62","author":"PARK","year":"2021","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.radcr.2024.03.051_bib0009","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2967\/jnumed.114.144386","article-title":"High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation[J]","volume":"55","author":"Bahri","year":"2014","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.radcr.2024.03.051_bib0010","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance[J]","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.radcr.2024.03.051_bib0011","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/RLU.0000000000004139","article-title":"177 Lu-DOTATATE PRRT for multiple unusual metastatic sites in neuroendocrine tumor","volume":"47","author":"Parghane","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.radcr.2024.03.051_bib0012","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/diagnostics11050771","article-title":"Diagnosis and management of rectal neuroendocrine tumors (NETs)","volume":"11","author":"Maione","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"10.1016\/j.radcr.2024.03.051_bib0013","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/cas.15327","article-title":"Neuroendocrine tumor theranostics","volume":"113","author":"Ichikawa","year":"2022","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.radcr.2024.03.051_bib0014","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/RLU.0000000000002358","article-title":"Distinct imaging characteristics of different metastases from primary prostate adenocarcinoma and rectal carcinoid tumor on 18F-Fluciclovine and 68Ga-DOTATATE PET\/CT","volume":"44","author":"Bosserman","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.radcr.2024.03.051_bib0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11864-022-00967-z","article-title":"New PET radiotracers for the imaging of neuroendocrine neoplasms","volume":"23","author":"Fortunati","year":"2022","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.radcr.2024.03.051_bib0016","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.beem.2016.01.003","article-title":"Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - imaging and staging","volume":"30","author":"Baumann","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.radcr.2024.03.051_bib0017","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/MNM.0000000000001255","article-title":"Ga-68 DOTATATE PET\/CT and F-18 FDG PET\/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors","volume":"41","author":"You","year":"2020","journal-title":"Nucl Med Commun"},{"issue":"5","key":"10.1016\/j.radcr.2024.03.051_bib0018","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.radcr.2024.03.051_bib0019","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00259-017-3925-8","article-title":"Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index","volume":"45","author":"Nicolini","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.radcr.2024.03.051_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2967\/jnumed.116.178095","article-title":"Comparison of the impact of 68Ga-DOTATATE and 18F-FDG PET\/CT on clinical management in patients with neuroendocrine tumors","volume":"58","author":"Panagiotidis","year":"2017","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.radcr.2024.03.051_bib0021","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/17474124.2019.1685381","article-title":"177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors","volume":"13","author":"Das","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.radcr.2024.03.051_bib0022","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1634\/theoncologist.2017-0278","article-title":"Clinical usefulness of 18F-Fluorodeoxyglucose positron emission tomography in the diagnostic algorithm of advanced entero-pancreatic neuroendocrine neoplasms","volume":"23","author":"Rinzivillo","year":"2018","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.radcr.2024.03.051_bib0023","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-020-00651-z","article-title":"Tumour-to-liver ratio determined by [68Ga] Ga-DOTA-TOC PET\/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours","volume":"10","author":"Kim","year":"2020","journal-title":"EJNMMI Res"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043324002541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043324002541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T09:10:39Z","timestamp":1733217039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043324002541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1930043324002541"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2024.03.051","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of 18F-FDG PET\/CT and 18F-DOTATATE PET\/CT in the diagnosis of multiple metastases in rectal neuroendocrine neoplasms","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2024.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}